Sedat Evran - 20 Oct 2025 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role
EVP, Global Supply Chain
Signature
/s/ Sedat Evran
Issuer symbol
BIO
Transactions as of
20 Oct 2025
Net transactions value
-$107,836
Form type
4
Filing time
21 Oct 2025, 16:42:00 UTC
Previous filing
09 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
EVRAN SEDAT EVP, Global Supply Chain C/O BIO-RAD LABORATORIES, INC., 1000 ALFRED NOBEL DRIVE, HERCULES /s/ Sedat Evran 21 Oct 2025 0001993147

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIO BIO.B Bio-Rad A Common Stock Options Exercise $0 +1,044 +69% $0.000000 2,568 20 Oct 2025 Direct F1
transaction BIO BIO.B Bio-Rad A Common Stock Tax liability $107,836 -335 -13% $321.90 2,233 20 Oct 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO BIO.B Restricted Stock Units Options Exercise $0 -1,044 -33% $0.000000 2,088 20 Oct 2025 Bio-Rad A Common Stock 1,044 $0.000000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Class A common stock acquired on the vesting of restricted stock units.
F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F3 On October 20, 2023, the reporting person was granted 4,176 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.